Drug Type Small molecule drug |
Synonyms- |
Target |
Action degraders |
Mechanism IRAK1 degraders(Interleukin-1 receptor-associated kinase 1 degraders), IRAK4 degraders(Interleukin-1 receptor-associated kinase 4 degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Conjunctivitis | Discovery | - | 27 Feb 2025 | |
| Dermatomyositis | Discovery | - | 27 Feb 2025 | |
| Hepatitis | Discovery | - | 27 Feb 2025 | |
| Immune System Diseases | Discovery | - | 27 Feb 2025 | |
| Neoplasms | Discovery | - | 27 Feb 2025 | |
| Nephritis | Discovery | - | 27 Feb 2025 | |
| Pulmonary Disease, Chronic Obstructive | Discovery | - | 27 Feb 2025 | |
| Thyroiditis | Discovery | - | 27 Feb 2025 |





